相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Non-HIV-infected patients with Pneumocystis pneumonia in the intensive care unit: A bicentric, retrospective study focused on predictive factors of in-hospital mortality
Yuqiong Wang et al.
CLINICAL RESPIRATORY JOURNAL (2022)
Evaluating the risk-to-benefit ratio of using cotrimoxazole as a pneumocystis pneumonia preventative intervention among pemphigus patients treated with rituximab: A retrospective study with 494 patients
Hannaneh Faraji et al.
DERMATOLOGIC THERAPY (2022)
Nomograms for Death from Pneumocystis jirovecii Pneumonia in HIV-Uninfected and HIV-Infected Patients
Qiuyue Feng et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2022)
Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America
Sara E. Sabbagh et al.
RHEUMATOLOGY (2021)
Efficacy and safety of trimethoprim-sulfamethoxazole for the prevention of pneumocystis pneumonia in human immunodeficiency virus-negative immunodeficient patients: A systematic review and meta-analysis
Rui Li et al.
PLOS ONE (2021)
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
Dedee F. Murrell et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect
D. M. Chen et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Pneumocystis pneumonia occurrence and prophylaxis duration in kidney transplant recipients according to perioperative treatment with rituximab
Young Hoon Kim et al.
BMC NEPHROLOGY (2020)
Risk Factors and Prevention of Pneumocystis jirovecii Pneumonia in Patients With Autoimmune and Inflammatory Diseases
Amine Ghembaza et al.
CHEST (2020)
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
P. Joly et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study
Benjamin Jean Gaborit et al.
ANNALS OF INTENSIVE CARE (2019)
Fungal Diseases in Taiwan-National Insurance Data and Estimation
Yu-Shan Huang et al.
JOURNAL OF FUNGI (2019)
Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis
Andreas Kronbichler et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Sixteen-year history of rituximab therapy for 1085 pemphigus vulgaris patients: A systematic review
Soheil Tavakolpour et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Pneumocystis jirovecii pneumonia in HIV-uninfected, rituximab treated non-Hodgkin lymphoma patients
Kai-Che Wei et al.
SCIENTIFIC REPORTS (2018)
Prevention and management of glucocorticoid- induced side effects: A comprehensive review
Avrom Caplan et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Rituximab as first-line treatment of pemphigus
Enno Schmidt
LANCET (2017)
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
Pascal Joly et al.
LANCET (2017)
Risk factors for mortality from pneumocystis carinii pneumonia (PCP) in non-HIV patients: a meta-analysis
Yao Liu et al.
ONCOTARGET (2017)
Determining the Incidence of &ITPneumocystis&IT Pneumonia in Patients With Autoimmune Blistering Diseases Not Receiving Routine Prophylaxis
Kyle T. Amber et al.
JAMA DERMATOLOGY (2017)
Pemphigus
Michael Kasperkiewicz et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Pneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions: a systematic review with recommendations for prophylaxis
Tania M. Gonzalez Santiago et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2016)
ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients
Johan Maertens et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010
Kate Buchacz et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Anti-CD20 Antibody Therapy and Susceptibility to Pneumocystis Pneumonia
Waleed Elsegeiny et al.
INFECTION AND IMMUNITY (2015)
Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014
L. Cooley et al.
INTERNAL MEDICINE JOURNAL (2014)
Pneumocystis jiroveci pneumonia in immunocompromised patients: Delayed diagnosis and poor outcomes in non-HIV-infected individuals
Ming-Chi Li et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2014)
Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients
Anat Stern et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy
Dora Liu et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2013)
The Increased Risk for Pneumocystis Pneumonia in Patients Receiving Rituximab-CHOP-14 Can Be Prevented by the Administration of Trimethoprim/Sulfamethoxazole: A Single-Center Experience
Emilia Hardak et al.
ACTA HAEMATOLOGICA (2012)
Colonization by Pneumocystis jirovecii and Its Role in Disease
Alison Morris et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy
Anat Gafter-Gvili et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Considerations when prescribing trimethoprim-sulfamethoxazole
Joanne M. -W. Ho et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2011)
Development of Pneumocystis carinii pneumonia in patients with immunobullous and connective tissue disease receiving immunosuppressive medications
Jacqueline L. Gerhart et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Role of primary prophylaxis for pneumocystis pneumonia in patients treated with systemic corticosteroids or other immunosuppressive agents for immune-mediated dermatologic conditions
Julia S. Lehman et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort
A. S. Walker et al.
LANCET (2010)
Prophylactic Antibiotic Usage for Pneumocystis jirovecii Pneumonia in Patients With Systemic Lupus Erythematosus on Cyclophosphamide A Survey of US Rheumatologists and the Review of Literature
Deepak Gupta et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2008)
Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients:: Systematic review and meta-analysis of randomized controlled trials
Hefziba Green et al.
MAYO CLINIC PROCEEDINGS (2007)
Treatment of severe pemphigus with rituximab - Report of 12 cases and a review of the literature
Giuseppe Cianchini et al.
ARCHIVES OF DERMATOLOGY (2007)
Rituximab in autoimmune bullous diseases:: mixed responses and adverse effects
E. Schmidt et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Medical Pearl: Pneumocystis pneumonia prophylaxis for patients on chronic systemic corticosteroids
Chad M. Lemaire et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Rituximab, an anti-CD20 monoclonal antibody: History and mechanism of action
MD Pescovitz
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab)
LH Morrison
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
New approaches to the treatment of pemphigus
SA Grando
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2004)
Pneumocystis carinii pneumonia in patients with malignant haematological diseases:: 10 years' experience of infection in GIMEMA centres
L Pagano et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Side effects of corticosteroid therapy
AL Buchman
JOURNAL OF CLINICAL GASTROENTEROLOGY (2001)
Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995 - Comparison of HIV-associated cases to other immunocompromised states
NG Mansharamani et al.
CHEST (2000)
分享论文
